Abbott Laboratories (US) was the second-largest player in the market in 2018. Over the last few years, the company has been investing approximately 6-9% of its total revenue on R&D. As a result, the company has been able to introduce products, such as Abbott RealTime IDH1 and Abbott RealTime IDH2 assay kits, into the market. What the Market Looks Like? The hemato oncology testing market is projected … Continue reading Global Hemato Oncology Testing Market is Going Through Major Technological Transformations